Skip to main content

Sources last read

Brand guide · Semaglutide

What is Wegovy?

Wegovy is semaglutide for weight management in adults and teens.

Source for this answer

Source: Current FDA label, checked 2026-08-12

Source: Current FDA label, checked 2026-08-12

Explore Wegovy

Injection dose scheduleSee every labeled step from 0.25 mg to 7.2 mg.Tablet dose scheduleSee the tablet strengths, daily schedule and approved uses.Side effectsSee common trial results, serious warnings and later FDA reports.Weight-loss resultsSee the weeks and study groups behind the reported averages.Cost and coverageCompare the list price, published cash offers and key limits.Storage and travelCheck the label rules for temperature, travel and time out of the fridge.About SemaglutideSee the medicine behind Wegovy and any other brands that use it.Does a Wegovy patch exist?Read the patch evidence and regulatory record.

Approved uses

What is Wegovy approved to treat?

Adults with obesity, or with overweight plus at least one related health condition.

Labeled maintenance: 1.7 mg or 2.4 mg once weekly, 2.4 mg recommended

People age 12 and older with obesity.

Labeled maintenance: 2.4 mg recommended, or 1.7 mg once weekly

Adults with heart disease and obesity or overweight, to lower the risk of heart attack, stroke and heart-related death.

Labeled maintenance: 2.4 mg recommended, or 1.7 mg once weekly

Adults with MASH and moderate to advanced liver scarring, but without cirrhosis.

Labeled maintenance: 2.4 mg once weekly, reducible to 1.7 mg if not tolerated

Not an approved use: The Wegovy label does not cover type 2 diabetes. It never sets a dose for blood sugar control.

The product itself

Available forms and strengths

Single-dose pen

0.25, 0.5, 1, 1.7, 2.4 and 7.2 mg (7.2 mg as Wegovy HD)

1 dose

Single-dose syringe

0.25, 0.5, 1, 1.7 and 2.4 mg

1 dose

Single-patient-use pen (Wegovy FlexTouch)

9.6 mg/3 mL, delivering 2.4 mg per dose

4 doses

Tablet

The Wegovy tablet comes in 1.5, 4, 9 and 25 mg. It is taken once a day, on an empty stomach, with water. The label starts with 30 days each at 1.5, 4 and 9 mg, followed by 25 mg once daily as the maintenance dose. The tablet covers only two of the four approved uses: heart risk reduction, and weight reduction in adults.

Tablet dose schedule
Injection dose facts

What matters first

Medicine
Semaglutide
How often
Once weekly, on the same day each week, at any time of day
Starting dose
0.25 mg
Highest labeled dose
7.2 mg

Novo Nordisk makes Wegovy under NDA 215256. Wegovy comes as a shot under the skin.

Same medicine, different label

How is Wegovy different from Ozempic?

Wegovy and Ozempic both contain semaglutide. Wegovy is approved for weight-related care. Ozempic is approved for type 2 diabetes. Their dose plans are not the same.

Read the Ozempic overview
8primary sources, each with the day we read it — open the documents used on this page

Medically reviewed by Jennifer Montecillo, MD · non-practicing medical reviewer

This is an independent guide to Wegovy, a registered brand name. Novo Nordisk does not sponsor or endorse it. This guide explains public FDA records and does not give medical advice.